Cistron Biotechnology Inc saidit has reached a marketing agreement for a "major multinationalconsumer products company" it did not name to seek U.S. Foodand Drug Administration approvals for over the counter sales ofCistron's home test for detection of vaginal infections.    The company said product commercialization could take placewithin 18 months.  The new tests are expected to retail for 10to 20 dlrs each and take about 30 minutes for results to becomeknown.  It said its agreement with the major company alsocovers worldwide sales. Reuter&#3;